These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Analysis of mitochondrial DNA gene tRNALeu(UUR) A3243G mutation in diabetic pedigrees]. Wang CL, Li F, Hou QZ, Li HZ, Zhang Y, Ning G. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):74-7. PubMed ID: 19199257 [Abstract] [Full Text] [Related]
7. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Salles JE, Moisés VA, Almeida DR, Chacra AR, Moisés RS. Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379 [Abstract] [Full Text] [Related]
8. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus. da Silva RC, Miranda WL, Chacra AR, Dib SA. J Diabetes Complications; 2007 Apr; 21(2):84-92. PubMed ID: 17331856 [Abstract] [Full Text] [Related]
9. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM. Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952 [Abstract] [Full Text] [Related]
12. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y. Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051 [Abstract] [Full Text] [Related]
13. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Preumont V, Hermans MP, Lebecque P, Buysschaert M. Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503 [Abstract] [Full Text] [Related]
14. Diabetes mellitus associated with 3243 mitochondrial tRNA(Leu(UUR)) mutation: clinical features and coenzyme Q10 treatment. Suzuki Y, Taniyama M, Muramatsu T, Atsumi Y, Hosokawa K, Asahina T, Shimada A, Murata C, Matsuoka K. Mol Aspects Med; 1997 May; 18 Suppl():S181-8. PubMed ID: 9266520 [Abstract] [Full Text] [Related]